About Us
Overview
Our History
Leadership Team
Partner
Portfolio Advisory Board
Media Center
Our Science
Science & Innovation
Dorzagliatin
mGluR5
Presentations
Peer Reviewed Publications
Products&Pipeline
Pipeline
HuaTangNing(华堂宁®)
Media
Company News
Media Releases
Video
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information (2552.HK)
Corporate Communications
Careers
Company Culture
Join Us
Contact Us
中
中
中

Our Science

 >  Our Science
 >  Presentations
Science & Innovation
Dorzagliatin
mGluR5
Presentations
Peer Reviewed Publications

多格列艾汀治疗30天改善高脂饮食诱导肥胖小鼠的GLP-1分泌功能（2025 CDS）

2025 CDS
May 25, 2026
504
Share

Online link unavailable, presentation available upon request. (BD@huamedicine.com)

Return list
Previous Page：
多格列艾汀联合恩格列净改善T2DM患者胰岛素敏感性与β细胞功能的机制研（2025 CDS）
Next Page：
葡萄糖激酶突变对酶活性及多格列艾汀敏感性的结构机制研究（2025 CDS）
About Us
Overview
Our History
Leadership Team
Portfolio Advisory Board
Partner
Media center
Research & Development
Inovation
Dorzagliatin
mGluR5
Presentations
Peer Reviewed Publications
Media
Company News
Media Releases
Video
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Careers
Culture
Join Us
Products&Pipeline
Pipeline
HuaTangNing(华堂宁®)
Focus Us
Copyright © 2025  Hua Medicine (Shanghai) Ltd.    沪网药械信备字【2026】000123号
沪ICP备14036654号-1  beiantubiao.png 沪公网安备 31011502013809号  Privacy Statement  Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
Accept
x